STXBP5
Basic information
Region (hg38): 6:147204180-147391010
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the STXBP5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 14 | ||||
missense | 49 | 55 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 3 | |||||
Total | 0 | 0 | 49 | 16 | 8 |
Variants in STXBP5
This is a list of pathogenic ClinVar variants found in the STXBP5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-147204527-G-A | STXBP5-related disorder | Benign (Jan 25, 2023) | ||
6-147204546-A-G | not specified | Uncertain significance (Dec 13, 2023) | ||
6-147205993-A-G | not specified | Uncertain significance (Oct 24, 2023) | ||
6-147206022-G-C | not specified | Uncertain significance (Feb 15, 2023) | ||
6-147235250-C-T | STXBP5-related disorder | Likely benign (Apr 19, 2024) | ||
6-147239221-C-T | not specified | Uncertain significance (Feb 07, 2023) | ||
6-147239239-A-G | not specified | Uncertain significance (Aug 17, 2022) | ||
6-147260720-C-T | STXBP5-related disorder | Likely benign (May 24, 2019) | ||
6-147262345-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
6-147267078-T-C | Likely benign (Sep 01, 2022) | |||
6-147267084-C-G | not specified | Uncertain significance (Jan 18, 2023) | ||
6-147267146-C-T | STXBP5-related disorder | Likely benign (Jun 24, 2019) | ||
6-147278112-G-A | not specified | Uncertain significance (Nov 10, 2021) | ||
6-147278144-A-G | not specified | Uncertain significance (May 23, 2023) | ||
6-147278153-A-G | STXBP5-related disorder | Likely benign (Jul 16, 2023) | ||
6-147278164-A-G | STXBP5-related disorder | Likely benign (Jun 15, 2021) | ||
6-147311462-A-G | STXBP5-related disorder | Likely benign (Jan 28, 2024) | ||
6-147311523-A-G | STXBP5-related disorder | Uncertain significance (Sep 28, 2022) | ||
6-147313944-C-T | STXBP5-related disorder | Likely benign (Jul 21, 2018) | ||
6-147313972-C-G | STXBP5-related disorder | Likely benign (Feb 01, 2023) | ||
6-147315592-A-G | STXBP5-related disorder | Uncertain significance (Dec 20, 2023) | ||
6-147315617-A-G | STXBP5-related disorder | Benign (May 17, 2018) | ||
6-147315687-C-G | STXBP5-related disorder | Likely benign (Apr 25, 2023) | ||
6-147315734-C-T | not specified | Uncertain significance (Feb 28, 2024) | ||
6-147315744-G-A | STXBP5-related disorder | Likely benign (Aug 13, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
STXBP5 | protein_coding | protein_coding | ENST00000321680 | 28 | 181306 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000441 | 125734 | 0 | 12 | 125746 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.00 | 401 | 609 | 0.658 | 0.0000313 | 7451 |
Missense in Polyphen | 58 | 128.97 | 0.44971 | 1561 | ||
Synonymous | 0.178 | 221 | 224 | 0.985 | 0.0000122 | 2234 |
Loss of Function | 6.41 | 10 | 66.3 | 0.151 | 0.00000348 | 821 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000579 | 0.0000579 |
Ashkenazi Jewish | 0.000100 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000361 | 0.0000352 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000662 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a regulatory role in calcium-dependent exocytosis and neurotransmitter release. Inhibits membrane fusion between transport vesicles and the plasma membrane. May modulate the assembly of trans-SNARE complexes between transport vesicles and the plasma membrane. Inhibits translocation of GLUT4 from intracellular vesicles to the plasma membrane. Competes with STXBP1 for STX1 binding (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.143
Intolerance Scores
- loftool
- 0.305
- rvis_EVS
- -0.4
- rvis_percentile_EVS
- 26.98
Haploinsufficiency Scores
- pHI
- 0.176
- hipred
- Y
- hipred_score
- 0.749
- ghis
- 0.439
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.733
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Stxbp5
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- exocytosis;protein transport;regulation of exocytosis;positive regulation of GTPase activity;positive regulation of exocytosis;synaptic vesicle cycle
- Cellular component
- cytoplasm;cytosol;plasma membrane;acetylcholine-gated channel complex;synaptic vesicle;cell junction;cytoplasmic vesicle membrane;SNARE complex;neuromuscular junction;Schaffer collateral - CA1 synapse;extrinsic component of presynaptic membrane;presynaptic cytosol
- Molecular function
- GTPase activator activity;syntaxin-1 binding;Rab GTPase binding;syntaxin binding